Opioids

Claire Pinelli LADC, CCS, ICAADC, MCAP

April 21, 2022

Emerging Opioid Threat From New Synthetic Drug

Nitazenes are a new type of opioid drug said to be 800 times more potent than morphine and 40 times more potent than fentanyl. This drug has not yet been approved for human consumption in the U.S., and it is not FDA approved. But could nitazenes become the next “super opioid” to hit the streets?

Matt Hawk BS, CADC-II, ICADC

May 2, 2022

Further Consequences of Drug Addiction Emerge

Researchers at the University of New England found that the rate of opioid-related cardiac arrests has risen dramatically and is now on par with the rate of cardiac arrest from other causes. The research sheds light on yet another major health risk connected to opioid addiction, i.e., the risk for suffering a potentially fatal heart complication.

Claire Pinelli LADC, CCS, ICAADC, MCAP

June 2, 2022

Treating Addiction Provides Lasting Economic Benefits

Though it is not often mentioned by the media, there is a broader economic cost to the national public health emergency of drug and alcohol addiction. Addiction is expensive, not just for addicts, but for all Americans. Conversely, solving America’s addiction epidemic and returning millions of recovering addicts to the workforce would benefit the economy.